Evidence map›Paper›PMID 39038657›Full record

ArticleCells & development2024

Identification of a fibronectin-binding protein signature associated with idiopathic pulmonary fibrosis.

Yu Sun, Benjamin King, Aaron J Hamlin, Mersedeh Saniepay, Kirill Gorshkov, Gregory Barker, Milinda Ziegler, Shilpaa Mukundan, Mary Ellen Cvijic, Jean E Schwarzbauer

Abstract read
In one paragraph

Article in Cells & development, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Airway Spatial Transcriptomics in Smoking.medRxiv : the preprint server for health sciences · 2025
    Article
  9. Article
  10. Journal of oral and maxillofacial pathology : JOMFP
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yu SunDepartment of Molecular Biology, Princeton University, Princeton, NJ 08544, USA.
Benjamin KingLeads Discovery and Optimization, Bristol Myers Squibb, Lawrenceville, NJ 08648, USA.
Aaron J HamlinDepartment of Molecular Biology, Princeton University, Princeton, NJ 08544, USA.
Mersedeh SaniepayLeads Discovery and Optimization, Bristol Myers Squibb, Lawrenceville, NJ 08648, USA.
Kirill GorshkovLeads Discovery and Optimization, Bristol Myers Squibb, Lawrenceville, NJ 08648, USA.
Gregory BarkerLeads Discovery and Optimization, Bristol Myers Squibb, Lawrenceville, NJ 08648, USA.
Milinda ZieglerLeads Discovery and Optimization, Bristol Myers Squibb, Lawrenceville, NJ 08648, USA.
Shilpaa MukundanLeads Discovery and Optimization, Bristol Myers Squibb, Lawrenceville, NJ 08648, USA.
Mary Ellen CvijicLeads Discovery and Optimization, Bristol Myers Squibb, Lawrenceville, NJ 08648, USA.
Jean E SchwarzbauerDepartment of Molecular Biology, Princeton University, Princeton, NJ 08544, USA.

Funding

PREDOCTORAL TRAINING PROGRAM IN GENETICST32GM007388 · NIGMS · PRINCETON UNIVERSITY · PI CRISTEA, ILEANA M. · 1985 to 2022
$27.4M
Fibronectin-dependent mechanisms governing the assembly of a definitive extracellular matrixR01AR073236 · NIAMS · PRINCETON UNIVERSITY · PI SCHWARZBAUER, JEAN E · 2018 to 2022
$1.7M
NIAMS NIH HHS R01 AR073236NIGMS NIH HHS T32 GM007388
6 · The paper itself

Abstract

The extracellular matrix (ECM) is a critical component of tissue where it provides structural and signaling support to cells. Its dysregulation and accumulation lead to fibrosis, a major clinical challenge underlying many diseases that currently has little effective treatment. An understanding of the key molecular initiators of fibrosis would be both diagnostically useful and provide potential targets for therapeutics. The ECM protein fibronectin (FN) is upregulated in fibrotic conditions and other ECM proteins depend on assembly of a FN foundational ECM for their matrix incorporation. We used cell culture and in vivo models to investigate the role of FN in the progression of lung fibrosis. We confirmed that normal human lung fibroblasts (NHLFs) treated with transforming growth factor-beta (TGF-β) to stimulate fibrotic gene expression significantly increased both FN expression and its assembly into a matrix. We found that levels of alternatively spliced EDA and EDB exons were proportional to the increase in total FN RNA and protein showing that inclusion of these exons is not enhanced by TGF-β stimulation. RNA-sequencing identified 43 core matrisome genes that were significantly up- or down-regulated by TGF-β treatment and a Luminex immunoassay demonstrated increased levels of ECM proteins in conditioned medium of TGF-β-treated NHLFs. Interestingly, among the regulated core matrisome genes, 16 encode known FN-binding proteins and, of these, insulin-like growth factor binding protein 3 (IGFBP3) was most highly up-regulated. To link the NHLF results with in vivo disease, we analyzed lung tissue and bronchoalveolar lavage fluid from bleomycin-treated mice and found dramatically higher levels of FN and the FN-binding proteins IGFBP3, tenascin-C, and type I collagen in fibrotic conditions compared to controls. Altogether, our data identify a set of FN-binding proteins whose upregulation is characteristic of IPF and suggest that FN provides the foundational matrix for deposition of these proteins as fibrosis develops.

Indexed as

FibronectinsIdiopathic Pulmonary FibrosisTransforming Growth Factor betaAlternative SplicingAnimalsBleomycinCells, CulturedExtracellular MatrixFibroblastsHumansInsulin-Like Growth Factor Binding Protein 3LungMiceMice, Inbred C57BLUp-RegulationBleomycinFibronectinsIGFBP3 protein, humanInsulin-Like Growth Factor Binding Protein 3Transforming Growth Factor betaBleomycinCore matrisomeFibronectinFibrosisLung fibroblasts

Identifiers

PMID39038657
PMCPMC11344656

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.